Sirona Biochem Corp Stock Shares Owned By Institutions
| SRBCF Stock | USD 0.05 0.01 12.50% |
Sirona Biochem Corp fundamentals help investors to digest information that contributes to Sirona Biochem's financial success or failures. It also enables traders to predict the movement of Sirona Pink Sheet. The fundamental analysis module provides a way to measure Sirona Biochem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sirona Biochem pink sheet.
Sirona |
Sirona Biochem Corp Company Shares Owned By Institutions Analysis
Sirona Biochem's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 0.0% of Sirona Biochem Corp are shares owned by institutions. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The shares owned by institutions for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Sirona Fundamentals
| Return On Equity | -35.56 | |||
| Return On Asset | -1.35 | |||
| Operating Margin | (4.92) % | |||
| Current Valuation | 24.5 M | |||
| Shares Outstanding | 251.73 M | |||
| Shares Owned By Insiders | 10.43 % | |||
| Price To Earning | (7.33) X | |||
| Price To Book | 36.93 X | |||
| Price To Sales | 36.46 X | |||
| Revenue | 268.02 K | |||
| Gross Profit | 199.25 K | |||
| EBITDA | (2.3 M) | |||
| Net Income | (2.31 M) | |||
| Cash And Equivalents | 1.13 M | |||
| Total Debt | 468.77 K | |||
| Debt To Equity | 0.60 % | |||
| Current Ratio | 2.60 X | |||
| Book Value Per Share | 0 X | |||
| Cash Flow From Operations | (2.16 M) | |||
| Earnings Per Share | (0.01) X | |||
| Number Of Employees | 12 | |||
| Beta | -0.36 | |||
| Market Capitalization | 20.74 M | |||
| Total Asset | 1.29 M | |||
| Retained Earnings | (12.03 M) | |||
| Working Capital | 692 K | |||
| Current Asset | 1.49 M | |||
| Current Liabilities | 801 K | |||
| Z Score | 10.5 | |||
| Net Asset | 1.29 M |
About Sirona Biochem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sirona Biochem Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sirona Biochem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sirona Biochem Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Sirona Pink Sheet
Sirona Biochem financial ratios help investors to determine whether Sirona Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sirona with respect to the benefits of owning Sirona Biochem security.